The Cannavist Issue 6 B2C | Page 87

But if CBD is so widely available and far cheaper to obtain, why not simply obtain it on the high street? Dr Mathew explains that it’s a matter of safety and consistency that you only get with a medicinal product. “No one actually knows what’s in high street CBD. I’m seeing patients saying, ‘this one has given me a stomach ulcer’ and that rings alarm bells. Who knows what’s in it? “If a patient has an allergy to a certain kind of oil, we know and can give a prescription that doesn’t have that oil in it.” Medical cannabis remains diffi cult to physically obtain, even outside the confi nes of the NHS. The clinic’s pharmacist has to pick up the medication from Amsterdam. It is then delivered to the patient within a few weeks. The clinic recommends that patients prescribed raw fl ower vape it for maximum bioavailability. If they are unsure how to use a vape, they are given a demonstration and recommend a device. After that, it’s a matter of trialling the prescription for one-to-three months, booking a follow-up appointment to confi rm that the medication is working and then being discharged and continue to get their prescription from the pharmacy. Dr Mathew hopes that it will be easier for doctors and patients to access medical cannabis as more evidence of its effi cacy and safety comes to light. He notes that public perceptions are changing, not just due to high-profi le cases in the UK but also increased awareness of models in countries that have more well-established medical cannabis programmes. “In Canada, they have opened shops where you can pick a unique formula of taste, fl avour and so on. It will get to that stage, but the UK has had such bad press that it will take a while to change. “People have been using cannabis off-license without a prescription, so we have a huge database and the studies have been done from using it on the street, so we don’t need the “When you dive into the research and look at receptors and pharmacological reactions, you understand that there is a use for this medication.” typical clinical trial process. But we do need exact science of what we’re getting and what we’re prescribing.” Medical Cannabis Clinics Patient, Male, 26.* “My original diagnosis was low mood and anxiety/depression. I came in today because I’ve not been able to deal with it myself or manage things lately. Luckily, I got a new diagnosis of emotionally unstable personality disorder, which has helped clear up a lot of things.” “I went through a bad episode of negative things happening while at uni. My friend recommended that I try cannabis and I did a bunch of research before I tried it and I found that it helped, at least whenever I was able to fi nd the right version of it on the street. CBD helped me a lot with managing the extremes of emotion. “My parents found out at that I’d been using cannabis, had a proper sit-down, and I told them it had essentially been a miracle because I hadn’t found any other treatment or any other support that would work majorly. Therapy at uni did help but once that stopped, all the progress that I’d made got reversed. Cannabis didn’t cure everything, but it helped stabilise it. My parents wanted me to go through the legal avenues, so my dad got things sorted with the clinic and it’s been exceptionally good. I’ve actually been able to address things that I hadn’t been able to talk about for more or less a decade now.” “I came here today and the doctor didn’t just immediately give me the medication. He went through the full diagnosis process, fi nding out the symptoms and past drug and alcohol use. I found that with some GPs, they just throw medication at you. But the doctor suggested a combination of talking therapy/CBT as well as mood stabilisers. It wasn’t just jumping straight into ‘shall we use cannabis as the cure for everything and fi x it?’, but ‘what will actually work to address the broader issue.’’’ *In the interest of doctor-patient confi dentiality, this gentleman’s name cannot be published. 87